M. McDonnell (Oranmore (Co Galway), Ireland), C. Rhee (Seoul, Republic of Korea), R. Russell (Lymington (Hampshire), United Kingdom)
Improvement in the drug delivery of salmeterol/fluticasone via a novel breath actuatedpressurized metered dose inhaler with a dose counter
J. Gogtay (Mumbai, India), A. Tambe (Mumbai, India), K. Rote (Mumbai, India), G. Malhotra (Mumbai, India), B. Sharma (Delhi, India), A. Bhatnagar (Delhi, India), V. Gaur (Mumbai, India)
|  |
Device handling study of a novel breath-actuated inhaler Synchrobreathe vs pMDI
S. Balamurugan (Chennai, India), K. Apte (Pune, India), B. Singh (Lucknow, India), A. Deb (Varanasi, India), C. Deshmukh (Mumbai, India), K. Modi (Mumbai, India), A. Godse (Mumbai, India), R. Dhar (Kolkata, India), K. Lahiri (Mumbai , India), V. Singh (Mumbai , India), H. Pandya (Ahmedabad, India), S. Rajan (Mumbai , India), A. Vaidya (Mumbai, India), V. Gaur (Mumbai, India), J. Gogtay (Mumbai, India)
| |
Time is Essential for Competant Inhaler Technique Training
B. Mehta (London, United Kingdom), S. Edwards (London, United Kingdom), N. Hopkinson (London, United Kingdom), A. Hare (London, United Kingdom), O. Usmani (London, United Kingdom)
|  |
Side effects of inhaled budesonide through different types of inhalers
O. Varunkiv (Ivano-Frankivsk, Ukraine), K. Ostrovska (Ivano-Frankivsk, Ukraine), M. Ostrovskyy (Ivano-Frankivsk, Ukraine), I. Savelikhina (Ivano-Frankivsk, Ukraine), N. Korzh (Ivano-Frankivsk, Ukraine)
| |
Patient centric optimisation of a successful soft mist inhaler
M. Meisenheimer (Ingelheim, Germany), M. Frank (Ingelheim, Germany), S. Kattenbeck (Ingelheim, Germany), A. Gardev (Ingelheim, Germany), R. Krampe (Dortmund, Germany), S. Leiner (Ingelheim, Germany), F. Weiland (Dortmund, Germany)
| |
Critical handling errors with dry-powder, metered dose and soft-mist inhaler devices in an observational COPD study
J. Sulku (Gävle, Sweden), C. Jansson (Uppsala, Sweden), H. Melhus (Uppsala, Sweden), H. Koyi (Gävle, Sweden), M. Hammarlund-Udenaes (Uppsala, Sweden), B. Ställberg (Uppsala, Sweden), K. Bröms (Gävle, Sweden), A. Malinovschi (Uppsala, Sweden), M. Högman (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), E. Nielsen (Uppsala, Sweden)
| |
Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber
J. Suggett (London, Canada), A. Ellery (London, Canada), C. Doyle (London, Canada), R. Ali (London, Canada), M. Nagel (London, Canada)
| |
In-vitro product performance of fluticasone furoate (FF)/umeclidinium (UMEC)/vilanterol (VI) delivered from a dry powder inhaler (DPI) using the Electronic Lung (EL) to replicate patient inhalation profiles
D. Prime (Ware, United Kingdom), M. Hamilton (Ware, United Kingdom), E. Taylor (Ware, United Kingdom)
| |
Analysis of peak inspiratory flow and use of dry powder inhalers in patients with chronic obstructive pulmonary disease
M. Uchoa Sales (FORTALEZA, Brazil), C. Sampaio (FORTALEZA, Brazil), T. Maciel B Noronha (FORTALEZA, Brazil), J. Ramalho Correa (FORTALEZA, Brazil), M. França Fonteneles (FORTALEZA, Brazil), P. Milen Firmino (FORTALEZA, Brazil)
| |
Computerised measurements of inhalation ability with two different devices in patients with severe COPD.
P. Thind (Stockholm, Sweden), M. Qvarfordt (Stockholm, Sweden), M. Anderson (Stockholm, Sweden)
| |
Does the number of inhalers used by patients with asthma and COPD determine number of mistakes in inhalation technique?
I. Domagala (Warsaw, Poland), M. Miszczuk (Warsaw, Poland), K. Luczak-Wozniak (Warsaw, Poland), M. Dabrowska (Warszawa, Poland), R. Krenke (Warszawa, Poland)
| |
Effectiveness of long-term treatment with erythromycin in patients with Asthma-COPD overlap syndrome
O. Nesterovska (Chernivtsi, Ukraine), G. Stupnytska (?. ??????????, Ukraine), O. Fediv (?. ??????????, Ukraine), A. Stupnytska (?. ??????????, Ukraine)
| |
Non-invasive sanitation of a bronchial tree with different phenotypes of chronic obstructive pulmonary disease
V. Antonov (Chelyabinsk, Russian Federation), G. Ignatova (Chelyabinsk, Russian Federation)
| |
Poor inhalation technique is a major determinant of acute exacerbations
A. Vanoverschelde (Ghent, Belgium), P. Van Der Wel (Ghent, Belgium), L. Lahousse (Ghent, Belgium)
| |
Mechanical non-invasive pursed-lip breathing ventilation for hypercapnic patients with COPD
C. Jünger (Borstel, Germany), S. Rüller (Borstel, Germany), M. Reimann (Borstel, Germany), L. Krabbe (Borstel, Germany), K. Gaede (Borstel, Germany), C. Lange (Borstel, Germany), C. Herzmann (Borstel, Germany)
| |
Annual FEV1% variation before and after augmentation therapy in severe alpha-1-antitrypsin deficiency
G. Gonçalves (Coimbra, Portugal), S. Cabral (Coimbra, Portugal), A. Lopes (Coimbra, Portugal)
| |
Clinical characteristics of physician diagnosed asthma-COPD overlap
H. Lee (Seoul, Republic of Korea), S. Chung (Seoul, Republic of Korea), Y. Yeo (Seoul, Republic of Korea), T. Park (Seoul, Republic of Korea), D. Park (Seoul, Republic of Korea), J. Moon (Seoul, Republic of Korea), T. Kim (Seoul, Republic of Korea), J. Sohn (Seoul, Republic of Korea), H. Yoon (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea)
| |
Serum immunoglobulin E (IgE) in COPD: analysis of the German COSYCONET cohort
M. Lommatzsch (Rostock, Germany), C. Herr (Homburg, Germany), R. Jörres (München, Germany), C. Vogelmeier (Marburg, Germany), R. Bals (Homburg, Germany)
| |
Respiratory point of care testing (R-POCT) to facilitate diagnosis and treatment in the community for COPD exacerbations
K. Roy (Hemel Hempstead, United Kingdom), A. Marau (Hemel Hempstead, United Kingdom), L. Gora (Hemel Hempstead, United Kingdom), G. Esmond (Hemel Hempstead, United Kingdom), C. Ciobanu (Kings Langley, United Kingdom), M. Buxton (Hemel Hempstead, United Kingdom)
| |